1. A metagenomic study of biliary microbiome change along the cholecystitis‐carcinoma sequence. Issue 2 (11th June 2020) Authors: Song, Xiaoling; Wang, Xu'an; Hu, Yunping; Li, Huaifeng; Ren, Tai; Li, Yongsheng; Liu, Liguo; Li, Lin; Li, Xuechuan; Wang, Ziyi; Huang, Wen; Bao, Runfa; Zhang, Yijian; Li, Maolan; Wang, Xuefeng; Liu, Feng; Gu, Jun; Zheng, Linhui; Wu, Wenguang; Liu, Yingbin Journal: Clinical and translational medicine Issue: Volume 10:Issue 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A role for p21‐activated kinase 7 in the development of gastric cancer. (23rd November 2012) Authors: Gu, Jun; Li, Keqiang; Li, Maolan; Wu, Xiangsong; Zhang, Lin; Ding, Qichen; Wu, Wenguang; Yang, Jiahua; Mu, Jiasheng; Wen, Hao; Ding, Qian; Lu, Jianhua; Hao, Yuan; Chen, Lei; Zhang, Wenjie; Li, Songgang; Liu, Yingbin Journal: FEBS journal Issue: Volume 280:Number 1(2013) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A ten N6‐methyladenosine‐related long non‐coding RNAs signature predicts prognosis of triple‐negative breast cancer. Issue 6 (2nd May 2021) Authors: Wu, Jie; Cai, Yan; Zhao, Gaiping; Li, Maolan Journal: Journal of clinical laboratory analysis Issue: Volume 35:Issue 6(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial. Issue 2 (28th February 2023) Authors: Yang, Mao; Zhao, Yuhao; Li, Yongsheng; Cui, Xuya; Liu, Fatao; Wu, Wenguang; Wang, Xu-An; Li, Maolan; Liu, Yun; Liu, Yingbin Journal: BMJ open Issue: Volume 13:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chloride intracellular channel 1 regulates the antineoplastic effects of metformin in gallbladder cancer cells. Issue 6 (22nd May 2017) Authors: Liu, Yongchen; Wang, Zheng; Li, Maolan; Ye, Yuanyuan; Xu, Yi; Zhang, Yichi; Yuan, Ruiyan; Jin, Yunpeng; Hao, Yajuan; Jiang, Lin; Hu, Yunping; Chen, Shili; Liu, Fatao; Zhang, Yijian; Wu, Wenguang; Liu, Yingbin Journal: Cancer science Issue: Volume 108:Issue 6(2017) Page Start: 1240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CLIC1 antibody conjugated nanoscale contrast agent as a sensitive and targeted molecular imaging probe for gallbladder cancer diagnosis. Issue 29 (2nd March 2016) Authors: Lu, Wei; Wang, Ning; Chu, YanYan; Zhou, Linzhu; Li, Maolan; Huang, Tao; Weng, Hao; Zhang, Yijian; Jiang, Lin; Hu, Yunping; Tan, Qinggang; Liu, Yingbin Journal: RSC advances Issue: Volume 6:Issue 29(2016) Page Start: 24104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer. Issue 49 (December 2015) Authors: Lu, Wei; Gao, Jian; Yang, Jingyun; Cao, Yang; Jiang, Lin; Li, Maolan; Zhang, Yijian; Zhou, Jian; Liu, Yingbin Other Names: Li. Jianfeng section editor. Journal: Medicine Issue: Volume 94:Issue 49(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer. Issue 49 (December 2015) Authors: Lu, Wei; Gao, Jian; Yang, Jingyun; Cao, Yang; Jiang, Lin; Li, Maolan; Zhang, Yijian; Zhou, Jian; Liu, Yingbin Editors: Li., Jianfeng Journal: Medicine Issue: Volume 94:Issue 49(2015) Page Start: e2244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway. (28th August 2018) Authors: Ma, Qiang; Zhang, Yijian; Liang, Haibin; Zhang, Fei; Liu, Fatao; Chen, Shili; Hu, Yunping; Jiang, Lin; Hao, Yajuan; Li, Maolan; Liu, Yingbin Journal: Cancer letters Issue: Volume 430(2018) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer. Issue 2 (1st May 2015) Authors: Cao, Yang; Liu, Xiyong; Lu, Wei; Chen, Yuanyuan; Wu, Xiangsong; Li, Maolan; Wang, Xu-an; Zhang, Fei; Jiang, Lin; Zhang, Yijian; Hu, Yunping; Xiang, Shanshan; Shu, Yijun; Bao, Runfa; Li, Huaifeng; Wu, Wenguang; Weng, Hao; Yen, Yun; Liu, Yingbin Journal: Cancer letters Issue: Volume 360:Issue 2(2015) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗